霈方

-0.50 (-0.41%)最後更新 2026-09-11

台灣 · 上櫃 · 生技醫療業

120.0026成交張數9.06本益比2.47股價淨值比2.50%殖利率2026-09-11資料日期

ROE 與 ROA

近四季合計;近十年

元

負債總額 / 資產總額

單季,億元;自由現金流 = 營業現金流 + 資本支出(負值)

季度	資產總額(億)	母公司權益(億)	負債比率	流動比率	每股淨值	ROE(近四季)	ROA(近四季)	營業現金流(億)	自由現金流(億)
2026Q2	14	11	21.0%	4.22	48.55	33.4%	24.9%	0.7	0.5
2026Q1	12	9	25.7%	3.40	40.77	24.9%	17.8%	1.0	0.9
2025Q4	11	9	19.3%	5.17	40.58	19.2%	15.5%	1.0	1.0
2025Q3	10	8	25.1%	3.72	34.89	17.3%	13.3%	0.2	-0.0
2025Q2	10	7	31.0%	3.25	30.83	19.3%	13.3%	0.2	-0.5
2025Q1	10	6	32.4%	3.51	29.55	19.0%	12.9%	0.3	0.1
2024Q4	8	7	19.7%	5.06	30.47	13.8%	10.8%	0.8	0.8
2024Q3	8	6	21.0%	5.55	29.27	12.0%	9.3%	0.2	0.1
2024Q2	9	6	30.9%	3.43	27.13	5.9%	4.1%	0.3	0.2
2024Q1	8	6	31.3%	3.36	25.93	6.9%	4.7%	0.0	0.0
2023Q4	8	6	24.0%	4.92	29.16	7.1%	5.3%	0.4	0.4
2023Q3	8	6	23.4%	5.08	28.22	8.7%	6.3%	0.5	0.5
2023Q2	9	6	29.0%	3.63	28.52	11.7%	8.0%	0.4	0.4
2023Q1	9	6	33.6%	3.18	27.27	9.9%	6.4%	0.1	0.1
2022Q4	9	7	27.3%	4.40	30.29	10.5%	7.5%	0.5	0.5
2022Q3	9	6	29.8%	3.89	29.20	8.9%	6.1%	0.2	0.1
2022Q2	9	6	32.3%	3.79	28.68	4.4%	3.0%	0.5	0.4
2022Q1	10	6	34.5%	3.53	28.08	3.4%	2.4%	0.4	0.3
2021Q4	9	6	29.7%	3.86	28.41	2.2%	1.6%	0.6	0.4
2021Q3	9	6	30.2%	3.81	27.81	1.7%	1.2%	-0.5	-0.6
2021Q2	9	6	26.8%	4.10	28.57	5.5%	4.0%	0.4	0.3
2021Q1	8	6	25.0%	3.83	28.26	5.9%	4.4%	0.3	0.3
2020Q4	8	6	24.3%	4.04	29.17	6.6%	5.0%	0.2	0.2
2020Q3	8	6	24.4%	4.10	28.72	10.8%	8.2%	0.2	0.2
2020Q2	8	6	25.8%	3.93	28.39	13.8%	9.8%	0.2	0.2
2020Q1	8	6	24.7%	3.96	27.99	14.0%	10.7%	0.5	0.5
2019Q4	8	6	24.7%	3.93	28.48	14.2%	10.8%	0.4	0.3
2019Q3	8	6	23.8%	3.93	26.94	14.5%	11.3%	0.2	0.2
2019Q2	8	6	32.6%	2.82	25.89	15.3%	10.3%	0.1	-0.1
2019Q1	8	6	22.4%	4.30	29.24	14.4%	11.5%	0.6	0.5
2018Q4	8	6	22.6%	4.12	28.46	17.0%	13.2%	0.0	0.0
2018Q3	7	6	20.4%	4.60	27.12	–	–	0.0	0.0
2018Q2	9	6	33.1%	2.90	26.00	–	–	0.2	0.1
2018Q1	8	7	17.7%	5.42	31.11	–	–	0.6	0.6